Jonas Bergh Selected Research

Jonas Bergh Research Topics

Disease

149	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2002
107	Neoplasms (Cancer) 05/2024 - 01/2002
19	Neoplasm Metastasis (Metastasis) 12/2023 - 03/2004
6	Nausea 01/2019 - 05/2007
5	Triple Negative Breast Neoplasms 10/2022 - 07/2014
5	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2012
5	Fatigue 05/2020 - 04/2011
5	Disease Progression 01/2020 - 11/2008
5	Vomiting 01/2019 - 05/2007
4	Lymphatic Metastasis 12/2023 - 11/2006
4	Neutropenia 01/2020 - 12/2005
4	Carcinoma (Carcinomatosis) 10/2019 - 07/2006
4	Multiple Myeloma 01/2019 - 11/2017
4	Diarrhea 01/2018 - 07/2014
3	Hypertension (High Blood Pressure) 01/2023 - 02/2015
3	Heart Failure 01/2023 - 09/2007
3	Heart Diseases (Heart Disease) 01/2022 - 09/2007
3	Inflammation (Inflammations) 01/2021 - 07/2014
3	Leukopenia 07/2020 - 04/2011
3	Aneuploidy (Aneuploid) 01/2020 - 03/2004
3	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2017
2	Pathologic Complete Response 01/2021 - 01/2018
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 12/2020 - 11/2008
2	Febrile Neutropenia 01/2020 - 01/2011
2	Infections 01/2020 - 01/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2020
2	Genomic Instability 05/2011 - 05/2011

Drug/Important Bio-Agent (IBA)

26	Estrogen ReceptorsIBA 05/2023 - 03/2004
22	Epirubicin (Ellence)FDA LinkGeneric 10/2022 - 01/2002
20	Hormones (Hormone)IBA 12/2023 - 02/2006
20	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2002
18	Biomarkers (Surrogate Marker)IBA 05/2023 - 07/2006
18	Docetaxel (Taxotere)FDA Link 01/2023 - 12/2007
17	Proteins (Proteins, Gene)FDA Link 05/2024 - 12/2003
16	Tamoxifen FDA LinkGeneric 01/2022 - 07/2003
15	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2002
15	Fluorouracil (Carac)FDA LinkGeneric 05/2020 - 01/2002
11	Phenobarbital (Luminal)FDA Link 10/2019 - 07/2005
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 09/2006
9	RNA (Ribonucleic Acid)IBA 05/2024 - 05/2004
8	Estrogens (Estrogen)FDA Link 01/2020 - 06/2006
7	human ERBB2 proteinIBA 03/2024 - 08/2011
7	Messenger RNA (mRNA)IBA 09/2021 - 01/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2006
5	B7-H1 AntigenIBA 05/2023 - 01/2019
5	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 01/2002
5	AnthracyclinesIBA 01/2022 - 12/2005
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 07/2009
5	taxaneIBA 12/2019 - 12/2007
5	Sunitinib (Sutent)FDA Link 01/2016 - 08/2009
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2024 - 08/2011
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 04/2023 - 01/2018
4	Aromatase InhibitorsIBA 12/2022 - 10/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 06/2003
4	ParaffinIBA 10/2016 - 03/2004
3	pertuzumabIBA 01/2023 - 07/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 01/2002
3	LigandsIBA 09/2021 - 11/2008
3	ErbB Receptors (EGF Receptor)IBA 08/2021 - 01/2011
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021 - 07/2009
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 01/2007
3	Taxoids (Taxanes)IBA 12/2019 - 12/2005
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 11/2017
3	Estrogen Receptor alphaIBA 01/2019 - 07/2006
3	Platelet-Derived Growth FactorIBA 11/2018 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 12/2003
3	Indicators and Reagents (Reagents)IBA 05/2011 - 09/2006
3	Methotrexate (Mexate)FDA LinkGeneric 03/2007 - 12/2005
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2006 - 01/2002
2	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 11/2022
2	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2021
2	Denosumab FDA Link 12/2022 - 08/2015
2	pembrolizumabIBA 10/2022 - 01/2020
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 11/2021 - 04/2016
2	Everolimus FDA Link 01/2021 - 01/2011
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
2	Cyclin D1IBA 01/2019 - 09/2012
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2015
2	EnzymesIBA 11/2018 - 12/2003
2	PanobinostatIBA 07/2018 - 01/2018
2	Monoclonal AntibodiesIBA 01/2018 - 01/2007
2	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2018
2	Capecitabine (Xeloda)FDA Link 12/2017 - 05/2007
2	Sorafenib (BAY 43-9006)FDA Link 12/2017 - 11/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 10/2016 - 07/2006
2	Fulvestrant (Faslodex)FDA Link 06/2012 - 10/2010
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2011 - 01/2011
2	Complementary DNA (cDNA)IBA 05/2010 - 03/2004

Therapy/Procedure

65	Therapeutics 11/2023 - 01/2002
41	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
21	Neoadjuvant Therapy 05/2024 - 01/2002
20	Adjuvant Chemotherapy 01/2023 - 12/2005
10	Radiotherapy 01/2022 - 01/2002
8	Immunotherapy 09/2021 - 01/2016
2	Precision Medicine 05/2023 - 11/2016
2	Segmental Mastectomy (Lumpectomy) 01/2021 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 04/2018 - 09/2014
2	Aftercare (After-Treatment) 11/2017 - 01/2016